Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 6/1999

01-10-1999

Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase

Authors: Katsuya Nakanishi, Jiro Fujimoto, Takahiro Ueki, Keigo Kishimoto, Tomoko Hashimoto-Tamaoki, Jun-ichi Furuyama, Toshifumi Itoh, Yutaka Sasaki, Eizo Okamoto

Published in: Clinical & Experimental Metastasis | Issue 6/1999

Login to get access
Metadata
Title
Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3-kinase
Authors
Katsuya Nakanishi
Jiro Fujimoto
Takahiro Ueki
Keigo Kishimoto
Tomoko Hashimoto-Tamaoki
Jun-ichi Furuyama
Toshifumi Itoh
Yutaka Sasaki
Eizo Okamoto
Publication date
01-10-1999
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 6/1999
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1006685218766

Other articles of this Issue 6/1999

Clinical & Experimental Metastasis 6/1999 Go to the issue

OriginalPaper

Cytogenetic analyses of secondary liver tumors reveal significant differences in genomic imbalances between primary and metastatic colon carcinomas

OriginalPaper

Expression and activation of pro-gelatinase A by human melanoma cell lines with different tumorigenic potential

OriginalPaper

Co-inoculation of human and murine carcinoma cells induces reciprocal suppression of metastasis by both cell lines

OriginalPaper

Phosphodiesterase type III inhibitor, cilostazol, inhibits colon cancer cell motility

OriginalPaper

A three-dimensional in-vitro model for the study of peritoneal tumour metastasis

OriginalPaper

Characterization of spontaneous metastasis in an aggressive breast carcinoma model using flow cytometry
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits